DNA damage is the starting point for nearly all cancers. Every cell in your body accumulates roughly 10,000 to 100,000 DNA lesions per day from normal metabolism alone, yet cancer remains relatively rare because your cells have powerful repair systems that fix the vast majority of that damage before it becomes permanent. Cancer develops when damage slips past those defenses and becomes a fixed mutation in a gene that controls cell growth.
The relationship between DNA damage and cancer is not one-to-one, though. A single instance of damage almost never causes cancer by itself. The process requires multiple mutations accumulating over time in the right combination of genes, which is why cancer is predominantly a disease of aging.
From Damage to Mutation to Cancer
DNA damage and DNA mutations are not the same thing. Damage refers to a chemical alteration in the structure of DNA, like a bulge, a break, or a modified letter in the genetic code. Most of the time, repair enzymes detect and fix that alteration before the cell divides. A mutation happens when the cell copies its DNA without fixing the damage first, locking the error into all future copies of that cell.
Many carcinogenic chemicals work by becoming chemically reactive inside the body and physically attaching to DNA, forming what scientists call adducts. These adducts distort the DNA structure and, if not repaired, cause the cell’s copying machinery to misread the genetic code. Not all adducts are equally dangerous. Some positions on a DNA letter are more likely to cause misreading than others. Methylating agents, for instance, produce their most consequential damage at a specific oxygen position on the letter G, causing it to be read as an A during replication.
But a single mutation in a random gene is almost never enough to cause cancer. Solid tumors typically contain 40 to 80 mutations that change the protein code, and of those, roughly 5 to 15 are “driver” mutations that actually push the cell toward uncontrolled growth. The rest are passengers, mutations that happened along the way but don’t contribute to the cancer’s behavior. This means cancer requires a long accumulation of the right mutations in the right genes, which is why decades can pass between an initial exposure and a diagnosis.
The Genes That Guard Against Cancer
Two categories of genes matter most. Tumor suppressor genes act as brakes on cell division, and oncogenes act as accelerators. Cancer typically requires mutations that disable the brakes and jam the accelerator at the same time.
The most important tumor suppressor is TP53, sometimes called the “guardian of the genome.” When DNA damage is detected, TP53 activates and forces the cell to pause its division cycle, giving repair enzymes time to work. If the damage is too severe to fix, TP53 triggers programmed cell death, eliminating the damaged cell entirely. When TP53 itself is mutated and stops working, damaged cells survive and keep dividing, passing their errors to daughter cells. Mutations in TP53 appear in roughly half of all human cancers.
BRCA1 and BRCA2 are another critical pair. These genes coordinate the repair of double-strand DNA breaks, the most dangerous type of damage. BRCA1 works with a network of other proteins to activate cell cycle checkpoints, stabilize chromosomes, and recruit repair enzymes to broken DNA. When either BRCA gene is mutated, cells lose a major repair pathway, and broken DNA accumulates rapidly. People who inherit a faulty copy of BRCA1 or BRCA2 face significantly elevated risks of breast, ovarian, and other cancers because their cells start with only one working copy. If the second copy is damaged during their lifetime, the cell loses its repair ability entirely. This is the “two-hit” model: the first hit (inherited) knocks out one copy, and the second hit (acquired) knocks out the other.
Where the Damage Comes From
About 80 percent of cancers are linked to environmental and lifestyle factors rather than purely inherited genetics. “Environmental” here includes everything outside your genome: diet, tobacco smoke, UV radiation, infections, alcohol, and air pollution. Diet alone may account for 35 to 40 percent of cancers, though the exact figure is debated.
Your own metabolism is a constant source of DNA damage. Normal energy production generates reactive oxygen species (free radicals) that attack DNA. The most studied product of this attack is a modified form of the DNA letter G called 8-oxoguanine. This damaged letter can trick the cell’s copying machinery into pairing it with the wrong partner, producing a G-to-T mutation. This specific mutation signature shows up frequently in cancer genomes.
UV radiation from sunlight causes a different and very recognizable pattern of damage. UV energy fuses adjacent letters in DNA (specifically two pyrimidines sitting next to each other) into a joined structure called a dimer. The most common product is the cyclobutane pyrimidine dimer, or CPD. These dimers cause cancer primarily through a chemical reaction called deamination: within the fused dimer, the letter C loses an amino group and becomes U (uracil), which the cell then reads as T during replication. The result is a characteristic C-to-T mutation that serves as a molecular fingerprint of UV-induced skin cancers.
How Your Cells Fix the Damage
Your cells run several overlapping repair systems, each specialized for different types of damage. Base excision repair handles small-scale damage like oxidized letters. Nucleotide excision repair removes bulkier distortions, including UV-induced dimers. Mismatch repair catches errors made by the copying machinery itself. Homologous recombination repairs dangerous double-strand breaks using the intact sister chromosome as a template.
When any of these systems fails, specific cancer patterns emerge. Defective mismatch repair leads to a condition called microsatellite instability, where short repetitive DNA sequences accumulate errors throughout the genome. This is the hallmark of Lynch syndrome, an inherited condition that sharply increases the risk of colorectal and endometrial cancers. Testing for microsatellite instability has become routine for newly diagnosed colorectal and endometrial tumors at many cancer centers, because it affects both prognosis and treatment options.
Defects in nucleotide excision repair cause xeroderma pigmentosum, a condition where people are extremely sensitive to sunlight and develop skin cancers at very young ages because they cannot repair UV-induced dimers. The mutations in a gene called ERCC2, which is central to this repair pathway, appear in up to 20 percent of muscle-invasive bladder cancers.
How Cancer Treatment Exploits DNA Damage
The same vulnerability that makes cancer cells dangerous also makes them treatable. Cancer cells often have broken repair systems, which means they depend heavily on whatever repair pathways they have left. If you knock out that remaining pathway with a drug, the cancer cell accumulates so much unrepaired damage that it dies.
This principle is called synthetic lethality, and PARP inhibitors are its best-known application. PARP is a protein that detects single-strand DNA breaks and initiates their repair. In healthy cells, blocking PARP is not a problem because other repair systems (particularly those involving BRCA1 and BRCA2) can compensate. But in cancer cells that already lack functional BRCA genes, blocking PARP removes their last remaining repair option. The drug doesn’t just prevent PARP from working; it traps the PARP protein on the DNA at the site of damage, creating a physical obstacle that blocks DNA replication and prevents other repair proteins from reaching the break.
This approach is now a standard treatment for certain ovarian, breast, and other cancers with BRCA mutations. It represents a broader shift in oncology toward matching treatments to the specific DNA repair defects present in each patient’s tumor, using genetic sequencing and biomarker tests to identify which repair pathways are compromised.
Why DNA Damage Usually Doesn’t Cause Cancer
Given the tens of thousands of DNA lesions each cell experiences daily, the fact that cancer requires decades to develop in most people is a testament to how effective these repair systems are. Multiple layers of protection work simultaneously: repair enzymes fix damage before replication, cell cycle checkpoints halt division when damage is detected, and programmed cell death eliminates cells that are too damaged to save. The immune system adds another layer by identifying and destroying cells that display abnormal proteins on their surface.
Cancer happens when enough of these layers fail in the same cell lineage over time. Each successive driver mutation gives that cell line a slight growth advantage, allowing it to expand and acquire additional mutations faster. The process is fundamentally one of evolution within the body: damaged cells that happen to gain growth advantages outcompete their neighbors, and over years or decades, a small cluster of abnormal cells becomes a tumor capable of spreading.